NOV
394 hedge funds and large institutions have $6.77B invested in NOV in 2023 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 129 increasing their positions, 147 reducing their positions, and 42 closing their positions.
661% more call options, than puts
Call options by funds: $67.7M | Put options by funds: $8.9M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
24% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 42
1% more funds holding
Funds holding: 390 → 394 (+4)
0.25% more ownership
Funds ownership: 92.76% → 93.01% (+0.25%)
9% less capital invested
Capital invested by funds: $7.44B → $6.77B (-$671M)
12% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 147
Top Buyers
| 1 |
SPC
Slate Path Capital
New York
|
+$82.3M |
| 2 |
Bank of New York Mellon
New York
|
+$66.7M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$60M |
| 4 |
RL
Ruffer LLP
London,
United Kingdom
|
+$46.9M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$24.5M |
Top Sellers
NOV Hedge Fund Activity: Q1 2023 in Review
394 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NOV (NOV) for Q1 2023, worth a combined $6.77B — down 9% from $7.44B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new NOV positions and 42 closed out — a net gain of 10 holders — while 129 added to existing stakes and 147 trimmed.
The largest buyer was Slate Path Capital, adding an estimated $82.3M. The largest seller was Harris Associates, cutting an estimated $146M.
- 394 institutional investors held NOV (NOV) as of Q1 2023, up from 390 in Q4 2022.
- Funds reported $6.77B of NOV stock for Q1 2023, down 9% quarter-over-quarter.
- 52 funds opened new NOV positions in Q1 2023 and 42 closed out, a net change of +10 holders.
- The largest NOV buyer in Q1 2023 was Slate Path Capital, an estimated $82.3M added.
- The largest NOV seller in Q1 2023 was Harris Associates, an estimated $146M sold.
Based on aggregated 13F filings for Q1 2023.